Concepedia

Publication | Open Access

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

5.4K

Citations

29

References

2005

Year

Abstract

Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.

References

YearCitations

Page 1